Clinical Trial Update: Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects [Phase 3]

View source ↗

Summary

Phase 3 study update evaluating how DVS SR and paroxetine affect the pharmacokinetics of desipramine in healthy subjects; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DVS SR
• Desipramine (desipramine)
• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depression | Phase 3 | Status: COMPLETED